This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Randomized, Double-Blind, 5-Arm, Parallel-Group,...
Clinical trial

A Randomized, Double-Blind, 5-Arm, Parallel-Group, 26-Week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in Combination With Metformin as Initial Combination Therapy in the Treatment of Subjects With Type 2 Diabete

Read time: 1 mins
Last updated:2nd May 2013
To assess the effect of the co-administration of canagliflozin and metformin XR compared with canagliflozin alone on HbA1c. To assess the effect of the co-administration of canagliflozin and metformin XR compared with metformin XR alone on HbA1c. To assess the safety and tolerability of the co-administration of canagliflozin and metformin XR, canagliflozin alone, and metformin XR alone.
Category Value
Study start date 2013-05-02

View full details